JD Supra: Mergers

AUGUST 5, 2024

GE HealthCare on July 25th, 2024, announced a collaboration with Amazon Web Services (AWS) to develop purpose-built foundation models and generative artificial intelligence (AI) applications. By: Knobbe Martens

Healthcare 274

Healthcare Utilities Collaboration IT 274

JD Supra: Mergers

AUGUST 2, 2024

antitrust regulators, particularly the Federal Trade Commission, have been stepping up scrutiny of private equity investments in healthcare. On March 5, the FTC, along with the U.S. Department of Justice and the U.S.

Private Equity 292

Private Equity Healthcare Equities Investment 292

JD Supra: Mergers

JUNE 12, 2025

The McGuireWoods Healthcare Private Equity and Finance Conference brings together leading investors, operators and advisers to explore trends shaping the healthcare dealmaking landscape.

Private Equity 152

Private Equity Healthcare Finance Finance 152

JD Supra: Mergers

JULY 8, 2025

Episode 16: Leading with Integrity: Dr. David Schreiner on Transforming Rural Healthcare - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower engages in a thought-provoking conversation with guest Dr. David Schreiner, former president and CEO of Katherine Shaw Bethea Hospital, which merged with OSF Healthcare in January 2025 to (..)

Healthcare 152

Healthcare Hospitality Medical Shares 152

JD Supra: Mergers

JULY 17, 2024

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”. By: Bass, Berry & Sims PLC

Healthcare 192

Healthcare Private Equity Equities Investors 192

JD Supra: Mergers

APRIL 1, 2025

The Ankura Healthcare Real Estate Strategy team monitors a wide variety of economic indicators to inform clients upcoming strategic endeavors. Here are the ones worth watching in 2025. By: Ankura

Healthcare 189

Healthcare Economics 189

JD Supra: Mergers

JANUARY 9, 2024

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. Healthcare Continuation Funds: Strategic Considerations - With a sluggish 2023 for platform exits, an increasing number of PE funds looked to continuation funds to offer.

Private Equity 201

Private Equity Healthcare Equities Funds 201

JD Supra: Mergers

OCTOBER 11, 2024

In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust enforcement and the healthcare industry. By: Fenwick & West LLP

Healthcare 177

Healthcare Trading 177

JD Supra: Mergers

JANUARY 24, 2025

The Act increases regulatory reporting obligations and oversight of healthcare transactions involving private equity sponsors, healthcare real estate investment trusts (REITs) and management services organizations (MSOs). Maura Healy signed An Act Enhancing the Market Review Process (the Act). By: McGuireWoods LLP

Healthcare 159

Healthcare Private Equity Investors Equities 159

JD Supra: Mergers

MARCH 15, 2024

From the West Coast Healthcare Desk is an ongoing series of Holland & Knight Healthcare Blog articles and alerts focused on healthcare industry developments and points of interest in the West Coast healthcare marketplace.

Healthcare 177

Healthcare Private Equity Equities 177

JD Supra: Mergers

JANUARY 10, 2024

Sustainability of our healthcare system was an interesting topic at Day 2 of the 42nd Annual J.P. Morgan Healthcare Conference. Paul Markovich, CEO of Blue Shield of California, expressed the concern that “[T]he status quo is an existential threat to our healthcare system.”

Healthcare 201

Healthcare IT 201

JD Supra: Mergers

SEPTEMBER 20, 2024

In the second quarter, federal and state antitrust enforcers continued their intense scrutiny of consolidation in the healthcare market by implementing new initiatives and laws designed to gather additional information regarding transactions and conduct in the space. By: Goodwin

Healthcare 183

Healthcare 183

JD Supra: Mergers

AUGUST 2, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Private Equity 171

Private Equity Healthcare Equities Investment 171

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

MARCH 29, 2024

On February 22, 2024, the Minnesota legislature introduced a bill (SF-4392 and companion bill HR-4206) which seeks to curb the control and acquisition over certain healthcare providers by private equity companies and real estate investment trusts (REITs). By: Lathrop GPM

Healthcare 201

Healthcare Investment Private Equity Equities 201

JD Supra: Mergers

FEBRUARY 28, 2024

In the second week of January, Goodwin and KPMG convened innovators, practitioners, regulators, and others for our annual symposium on the future of life sciences and healthcare. Morgan Healthcare Conference in San Francisco. This marked the fifth year that Goodwin co-hosted the symposium, which takes place during the annual J.P.

Healthcare 205

Healthcare IPO M&A 205

JD Supra: Mergers

MAY 1, 2024

Companies should prepare for increased regulatory scrutiny into healthcare transactions and increased emphasis on compliance programs. We are tracking the inquiry and summarize here the. By: Latham & Watkins LLP

Healthcare 177

Healthcare Corporation Trading 177

JD Supra: Mergers

OCTOBER 21, 2024

In the healthcare mergers and acquisitions (M&A) market, while deal volumes varied across different sectors, by and large the sure and steady pace of deal volume in Q2 continued into Q3.

Healthcare 171

Healthcare Mergers and Acquisitions M&A Mergers 171

JD Supra: Mergers

SEPTEMBER 17, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 183

Healthcare Private Equity Equities Investment 183

JD Supra: Mergers

JUNE 17, 2025

On June 9, 2025, Oregon enacted Senate Bill (“SB 951”). SB 951 significantly limits the ability of management services organizations (“MSOs”) and professional medical entities to engage in the traditional structures of private equity transactions. By: Benesch

Private Equity 165

Private Equity Equities Healthcare Medical 165

JD Supra: Mergers

JANUARY 17, 2025

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. As a result, sellers may be incentivized to explore market opportunities without requiring investors to gross-up purchase multiple premiums.

Healthcare 177

Healthcare Private Equity M&A Portfolio 177

JD Supra: Mergers

OCTOBER 3, 2024

3129), which would have required private equity funds and hedge funds to obtain consent before entering into certain healthcare transactions. 3129 into law, certain investments in a healthcare facility, provider, or provider. Gavin Newsom vetoed California Assembly Bill 3129 (A.B. The closely monitored legislative effort behind A.B.

Healthcare 165

Healthcare Investment Private Equity Consulting 165

JD Supra: Mergers

AUGUST 29, 2024

Driven by a growing wave of enforcer skepticism toward further healthcare consolidation, some state legislatures have begun to propose “mini-HSR” laws explicitly targeting healthcare transactions involving private equity firms or sponsors. By: Morgan Lewis

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

MARCH 12, 2024

2023 saw a significant uptick in antitrust scrutiny and enforcement, particularly in the healthcare space.

Healthcare 192

Healthcare Private Equity Mergers Equities 192

JD Supra: Mergers

DECEMBER 24, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 171

Healthcare Private Equity Equities Investment 171

JD Supra: Mergers

OCTOBER 14, 2024

2024 has been an eventful year for federal and state antitrust enforcement in healthcare with many in the industry wondering where do we go from here in 2025.

Healthcare 183

Healthcare 183

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. According to an article in the Wall Street Journal on April 18, 2024, 12 states have already passed legislation regulating private equity involvement in healthcare.

Private Equity 177

Private Equity Healthcare Equities 177

JD Supra: Mergers

JANUARY 7, 2025

As the healthcare industry heads into 2025, deals attorneys are optimistic as they look to falling interest rates and a potentially more business-friendly administration set to enter the White House. Originally published in Law360 - January 1, 2025. By: Latham & Watkins LLP

Healthcare 177

Healthcare Business 177

JD Supra: Mergers

AUGUST 15, 2024

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. With that backdrop, navigating the healthcare M&A landscape continues to be increasingly challenging, especially with an ever-evolving regulatory landscape. Although the U.S. Dry powder held by U.S.

Private Equity 177

Private Equity Healthcare Equities M&A 177

JD Supra: Mergers

JUNE 18, 2024

The following states have proposed, but not passed, additional state healthcare transaction notification laws. By: Goodwin

Healthcare 171

Healthcare 171

JD Supra: Mergers

JANUARY 15, 2025

5159), An Act Enhancing the Market Review Process (the Act), which, among other things, broadens the scope of the states existing healthcare transaction notification and review regime. On January 8, 2025, Massachusetts Governor Maura Healey signed House Bill 5159 (H.5159), By: Goodwin

Healthcare 165

Healthcare Private Equity Equities Investment 165

JD Supra: Mergers

JULY 9, 2024

Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all, corporate transactions are complex affairs that often hang on small details.

Healthcare 188

Healthcare Corporation Business 188

JD Supra: Mergers

JANUARY 14, 2025

Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q3 2024 in the United States. The total number of transactions decreased by 2.8 percent in the third quarter of 2024, following a decrease of 3.1 percent in the second quarter. percent.

Healthcare 165

Healthcare Mergers and Acquisitions Hospitality Mergers 165

JD Supra: Mergers

JUNE 3, 2024

Rapid digitalization in the health industry is set to drive M&A across the region - Digitalization is reshaping the global healthcare industry as demand for personalized, more accessible care fuels innovative market solutions. This fresh prioritization prompted a surge of investment and innovation, with the value of the global digital.

Healthcare 177

Healthcare M&A Management Investment 177

JD Supra: Mergers

FEBRUARY 11, 2025

The forecast for state antitrust enforcement, however, is much clearer, particularly with respect to the healthcare industry. The outlook for federal antitrust enforcement remains murky, at best, with uncertainty about whether the new federal HSR rules, merger guidelines, and existing enforcement actions.

Healthcare 165

Healthcare Mergers 165

JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill. By: Arnall Golden Gregory LLP

Private Equity 177

Private Equity Healthcare Equities Investment 177